Author:
Biswas Sima,Bagchi Angshuman
Reference43 articles.
1. Abdel-Ilah L, Veljović E, Gurbeta L, Badnjević A (2017) Applications of QSAR study in drug design. Int J Eng Res Technol (IJERT) 6(06):582
2. Augen J (2002) The evolving role of information technology in the drug discovery process. Drug Discov Today 7(5):315–323
3. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF et al (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (New York, NY) 251:802–804. https://doi.org/10.1126/science.1846706
4. Caldwell GW (2000) Compound optimization in early-and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens. Curr Opin Drug Discov Devel 3(1):30–41
5. Chao W-R et al (2007) Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block akt signaling. J Med Chem 50:3412–3415